Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,147,286 papers from all fields of science
Search
Sign In
Create Free Account
Peyronie Disease
Known as:
diseases peyronies
, Fibrous Cavernitides
, Fibrous Cavernitis
Expand
A condition characterized by hardening of the PENIS due to the formation of fibrous plaques on the dorsolateral aspect of the PENIS, usually…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
19 relations
Connective Tissue Cells
Connective and Soft Tissue
Fibroblasts
In Blood
Expand
Broader (3)
Disorder of male reproductive system
Fibromatosis
Penile Diseases
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Review of non-surgical treatment options for Peyronie's Disease
S. Larsen
,
L. Levine
International journal of impotence research
2012
Corpus ID: 7987519
Non-surgical treatment of Peyronie's disease (PD) has come a long way since it was first described in 1743. A myriad of treatment…
Expand
2010
2010
Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice.
M. Baumhäkel
,
F. Custodis
,
N. Schlimmer
,
U. Laufs
,
M. Böhm
Atherosclerosis
2010
Corpus ID: 10011366
Review
2008
Review
2008
Penile change following radical prostatectomy: Size, smooth muscle atrophy, and curve
A. Mccullough
Current Urology Reports
2008
Corpus ID: 39427337
Dr. Patrick Walsh’s description of nerve-sparing prostatectomy was an important landmark in the surgical treatment of prostate…
Expand
Highly Cited
2007
Highly Cited
2007
Erectile dysfunction in systemic sclerosis: effects of longterm inhibition of phosphodiesterase type-5 on erectile function and plasma endothelin-1 levels.
M. Proietti
,
A. Aversa
,
+6 authors
F. Salsano
Journal of Rheumatology
2007
Corpus ID: 36897050
OBJECTIVE To investigate the effects of prolonged inhibition of phosphodiesterase type-5, using once-daily long-acting…
Expand
Highly Cited
2001
Highly Cited
2001
Basic fibroblast growth factor expression in Peyronie's disease.
J. Mulhall
,
Jeremy D. Thom
,
T. Lubrano
,
T. V. Shankey
Journal of Urology
2001
Corpus ID: 35094175
PURPOSE Peyronie's disease is a fibromatosis resulting in scarring of the tunica albuginea. While the inciting event is believed…
Expand
Highly Cited
2000
Highly Cited
2000
Penile fibrotic changes after radical retropubic prostatectomy
S. J. Ciancio
,
E. Kim
BJU International
2000
Corpus ID: 8932033
Objective To investigate the type of penile deformity, response to treatment of and predictive factors for the formation of…
Expand
Highly Cited
1998
Highly Cited
1998
Treatment of Peyronie's disease by extracorporeal shockwave therapy: evaluation of our preliminary results.
Yaser M. Abdelsalam
,
Z. Budair
,
+5 authors
M. El-Akkad
Journal of endourology
1998
Corpus ID: 43491819
BACKGROUND Peyronie's disease is an idiopathic disorder of the penis that produces erectile dysfunction. It affects mainly the…
Expand
Highly Cited
1987
Highly Cited
1987
Fibrosis of corpus cavernosum after intracavernous injection of phentolamine/papaverine.
E. Larsen
,
T. Gasser
,
R. Bruskewitz
Journal of Urology
1987
Corpus ID: 39648107
Review
1985
Review
1985
Surgery for Peyronie's disease. A review of 200 patients.
M. Bailey
,
S. Yande
,
B. Walmsley
,
J. Pryor
British Journal of Urology
1985
Corpus ID: 6947972
Approximately 10% of patients with Peyronie's disease require surgery for penile angulation or erectile failure severe enough to…
Expand
1963
1963
LINITIS PLASTICA OR DIFFUSELY INFILTRATING TYPE OF CARCINOMA OF THE COLON.
B. Wolf
,
R. Marshak
Radiology
1963
Corpus ID: 43263374
The linitis plastica type of scirrhous carcinoma occurs most frequently in the stomach and is extraordinarily uncommon in the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE